...the academic work of co-founder Moin Saleem, a professor of pediatric renal medicine at the University of Bristol...

...and olfactory neurons showed high NRP1 expression.A University of Bristol...
...and Harvard German Center for Neurodegenerative Diseases University of Helsinki University of Bristol Angiotensin-converting...

...to co-develop its cell therapies. Mogrify already has one undisclosed partner. Parkwalk, 24Haymarket and the University of Bristol...

...clonoSEQ test (Informal), clonoSEQ Assay (Informal) Acadia Pharmaceuticals Inc. Adaptive Biotechnologies Eton Pharmaceuticals Inc. Evotec SE Innovative Medicines Initiative (IMI) Nektar Therapeutics University of Bristol Vanda...

...Medical Research Council Laboratory of Molecular Biology (MRC LMB) and professor of bioinformatics at the University of Bristol...
...collaborators: Duke NUS Medical School, Medical Research Council Laboratory of Molecular Biology (MRC-LMB), Monash University, University of Bristol...
...of Molecular Biology (MRC LMB), Cambridge, U.K. Mission Therapeutics Ltd., Cambridge, U.K. Riken, Wako, Japan University of Bristol...

...disruptors in any one of the binding pockets. Mark Bond, a senior lecturer at the University of Bristol...
...play in liver and kidney fibrosis. According to Mark Bond, a senior lecturer at the University of Bristol...
...Daix, France Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151), Tokyo Japan Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland University of Bristol...

...one score for oliceridine and did not specify the assay employed. Panelist Graeme Henderson, a University of Bristol...
...Brook University, Stony Brook, N.Y. Trevena Inc. (NASDAQ:TRVN), Chesterbrook, Pa. University of Arizona, Tucson, Ariz. University of Bristol...

...insulin would likely reprice the insulin category, although it is a higher-risk project. Ziylo, a University of Bristol...

...co-founder and former Ph.D. adviser, Anthony Davis. Davis, who is professor of supramolecular chemistry at University of Bristol...
...Kenilworth, N.J. Novo Nordisk A/S (NYSE:NVO; CSE:NOVO B), Bagsvaerd, Denmark Sanofi (NYSE:SNY; Euronext:SAN), Paris, France University of Bristol...

...insulin would likely reprice the insulin category, although it is a higher-risk project. Ziylo, a University of Bristol...